Akebia Therapeutics, Inc. (AKBA)

1.685 +0.02 (+1.51%) USD  |  NASDAQ  |  Dec 12, 14:04
More

Akebia Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade